Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Inspiration Healthcare Group PLC

Healthcare GB IHC

26.5GBX
0.00(0%)

Last update at 2026-06-05T13:40:00Z

Day Range

26.2026.20
LowHigh

52 Week Range

12.3027.00
LowHigh

Fundamentals

  • Previous Close 26.50
  • Market Cap19.55M
  • Volume8398
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA1.65M
  • Revenue TTM45.20M
  • Revenue Per Share TTM0.50
  • Gross Profit TTM 20.06M
  • Diluted EPS TTM-0.14

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Income before tax -15.74800M -5.67600M 0.08M 3.96M 3.13M
Minority interest - - - - -
Net income -14.96700M -6.03400M 0.27M 3.59M 2.81M
Selling general administrative 4.78M 4.24M 16.50M 16.34M 14.78M
Selling and marketing expenses - 1.33M - - -
Gross profit 16.38M 17.89M 18.09M 20.59M 18.02M
Reconciled depreciation 2.21M 2.44M 2.29M 1.91M 1.23M
Ebit -14.65200M -4.86600M 1.63M 4.26M 3.25M
Ebitda -12.44300M -2.43000M 3.91M 6.17M 4.47M
Depreciation and amortization 2.21M 2.44M 2.29M 1.91M 1.23M
Non operating income net other - - - - -
Operating income -14.68600M -4.92700M 0.43M 4.25M 3.24M
Other operating expenses 52.94M 42.56M 39.64M 36.80M 33.74M
Interest expense 1.10M 0.81M 0.40M 0.30M 0.11M
Tax provision -0.78100M 0.36M -0.19600M 0.37M 0.32M
Interest income 0.03M 0.06M 0.04M 0.00900M 0.00300M
Net interest income -1.06200M -0.74900M -0.35500M -0.29200M -0.11100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.78100M 0.36M -0.19600M 0.37M 0.32M
Total revenue 38.25M 37.63M 41.23M 41.05M 36.98M
Total operating expenses 31.06M 22.81M 16.50M 16.34M 14.78M
Cost of revenue 21.87M 19.74M 23.14M 20.46M 18.96M
Total other income expense net -1.06200M -0.74900M -0.83100M -0.45300M -0.73700M
Discontinued operations - - - - -
Net income from continuing ops -14.96700M -6.03400M 0.27M 3.59M 2.81M
Net income applicable to common shares - - 0.27M 3.59M 2.81M
Preferred stock and other adjustments - - - - -
Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Total assets 41.08M 49.01M 54.89M 51.45M 43.23M
Intangible assets 5.00M 5.34M 9.39M 8.21M 6.64M
Earning assets - - - - -
Other current assets 1.27M 0.61M 9.31M 9.31M 5.16M
Total liab 24.45M 20.05M 19.42M 16.54M 11.66M
Total stockholder equity 16.64M 28.97M 35.47M 34.91M 31.58M
Deferred long term liab - - - 3.35M 1.41M
Other current liab 3.14M 2.15M 5.16M 4.19M 4.65M
Common stock 8.97M 6.82M 6.81M 6.81M 6.81M
Capital stock 8.97M 6.82M 6.81M 6.81M 6.81M
Retained earnings 4.16M 19.12M 25.58M 25.14M 21.96M
Other liab - - - 1.93M 1.14M
Good will 0.33M 7.94M 7.61M 8.57M 8.57M
Other assets - - 0.32M 3.82M 1.41M
Cash 0.73M 0.41M 2.28M 9.25M 10.65M
Cash and equivalents - - - - -
Total current liabilities 11.83M 9.57M 9.24M 7.72M 7.72M
Current deferred revenue - 0.62M -4.63200M -3.66500M -4.10900M
Net debt 14.24M 12.42M 10.80M -1.71000M -7.48800M
Short term debt 2.63M 2.35M 2.90M 0.65M 0.37M
Short long term debt 2.09M 1.65M 2.08M - -
Short long term debt total 14.97M 12.83M 13.08M 7.54M 3.17M
Other stockholder equity 3.51M 3.02M -32.39100M 2.95M -28.77200M
Property plant equipment - - 13.47M 9.18M 4.02M
Total current assets 25.15M 23.02M 24.10M 25.02M 24.01M
Long term investments - - - - -
Net tangible assets - - 18.47M 21.47M 17.78M
Short term investments - 0.20M - - -
Net receivables 10.06M 8.06M 11.89M 9.31M 4.92M
Long term debt 6.99M 5.00M 4.00M - -
Inventory 13.08M 13.74M 9.94M 6.45M 8.19M
Accounts payable 5.66M 4.36M 5.81M 6.55M 6.81M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 0.28M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 6.81M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 1.84M -25.31100M -21.65900M -
Deferred long term asset charges - - - - -
Non current assets total 15.93M 25.99M 30.80M 26.43M 19.23M
Capital lease obligations 5.90M 6.17M 7.00M 7.54M 3.17M
Long term debt total - - - - -
Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Investments -1.73900M -2.68500M -8.30200M -3.96200M -14.06000M
Change to liabilities - - -0.73300M -0.27500M -3.60300M
Total cashflows from investing activities -1.73900M -2.68500M -8.30200M -3.96200M -14.06000M
Net borrowings 2.42M 0.58M 5.60M -0.30800M -0.26200M
Total cash from financing activities 3.61M -1.19100M 4.80M -1.01400M 15.50M
Change to operating activities - - - - -
Net income -14.96700M -6.03400M 0.27M 3.59M 2.81M
Change in cash 0.32M -1.86400M -6.97700M -1.40000M 6.17M
Begin period cash flow 0.41M 2.28M 9.25M 10.65M 4.48M
End period cash flow 0.73M 0.41M 2.28M 9.25M 10.65M
Total cash from operating activities -1.54900M 2.01M -3.47100M 3.58M 4.74M
Issuance of capital stock 2.73M 0.00000M - 0.00000M 16.97M
Depreciation 2.21M 2.44M 2.29M 1.91M 1.23M
Other cashflows from investing activities -1.40700M -1.13700M 0.04M 0.00900M 0.00300M
Dividends paid - 0.42M 0.42M 0.41M 0.14M
Change to inventory 0.66M -3.37800M -3.48600M 1.74M -0.57300M
Change to account receivables -2.21400M 3.00M -2.50100M -4.03700M 4.01M
Sale purchase of stock - - - -15.46700M -15.46700M
Other cashflows from financing activities -1.53400M -1.34800M 5.21M -0.60200M 15.63M
Change to netincome - - 0.69M 0.34M 0.86M
Capital expenditures 1.97M 1.63M 8.34M 3.97M 0.92M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.81M 0.35M -6.72000M -2.26700M -0.16700M
Stock based compensation -0.11500M -0.05200M 0.13M 0.14M 0.08M
Other non cash items 10.52M 5.32M 0.33M -0.05800M 0.55M
Free cash flow -3.51900M 0.38M -11.81300M -0.39500M 3.81M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IHC
Inspiration Healthcare Group PLC		 - -% 26.50 - 13.76 0.43 1.20 0.71 11.75
SN
Smith & Nephew PLC		 14.50 1.28% 1147.00 23.24 12.47 1.70 2.59 2.67 10.76
NIOX
NIOX Group PLC		 -1.2 1.96% 60.00 28.20 18.73 4.84 3.41 4.35 13.85
EKF
EKF Diagnostics Holdings Plc		 -0.2 0.75% 26.40 - 34.97 2.02 1.46 1.72 7.01
CREO
Creo Medical Group PLC		 - -% 13.75 - - 199.36 0.74 6.21 8.16

Reports Covered

Stock Research & News

View All

Profile

Inspiration Healthcare Group plc designs, manufactures, and sells medical technology products worldwide. The company offers products for acute care comprising developmental and intensive care, monitoring, neonatal, obstetrics, operating theatres, pain management and developmental, respiratory, resus, thermo regulatory, and transport areas. It also offers infusion therapies and products, such as ambulatory infusion pumps, administration sets, accessories, patient infusion management systems, and medical infusion devices for acute pain management, obstetrics, parenteral nutrition, palliative care, oncology, immunoglobulin therapy, antibiotic infusion, and other, as well as manufactures and sells pneumatic ventilators. The company serves the hospital sector. Inspiration Healthcare Group plc was incorporated in 1998 and is based in Croydon, the United Kingdom.

Inspiration Healthcare Group PLC

Unit 7/8 Commerce Park, Croydon, United Kingdom, CR0 4YL

Key Executives

Name Title Year Born
Mr. Neil James Campbell CEO & Exec. Director 1968
Mr. William Norman Brook Nolson COO & Exec. Director 1964
Mr. Jonathan Ballard Exec. Director 1978
Dr. Peter Reynolds Group VP of Clinical, Research, Innovation & Compliance NA
Laura Edwards Group Head of Marketing NA
Mr. Simon Travers Head of Quality Assurance & Regulatory Affairs NA
Nigel Weston Head of Operations NA
Mr. William Graha Walls Fin. Director NA
Mr. Harout Rafi Stepanian CEO & Director 1969
Mr. Alan Musgrave Olby ACA, B.A. CFO & Director 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.